Results 201 to 210 of about 12,922 (226)

Identification of two major autoantigens negatively regulating endothelial activation in Takayasu arteritis

Nature Communications, 2020
Tomoyuki Mutoh, , Tomonori Ishii
exaly  

Takayasu Arteritis

2007
openaire   +1 more source

Retrospective Analysis of Surgery Versus Endovascular Intervention in Takayasu Arteritis

Circulation, 2012
David Saadoun, Marc Lambert, Tristan Mirault   +2 more
exaly  

Takayasu Disease

2008
openaire   +1 more source

Efficacy of Biological-Targeted Treatments in Takayasu Arteritis

Circulation, 2015
Arsene Mekinian, Tristan Mirault, Jean-Emmanuel Kahn   +2 more
exaly  

Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)

Annals of the Rheumatic Diseases, 2018
Yoshikazu Nakaoka, Mitsuaki Isobe, Syuji Takei   +2 more
exaly  

Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis

Annals of the Rheumatic Diseases, 2012
Peter C Grayson, Gunnar Tomasson, David Cuthbertson   +2 more
exaly  

Th1 and Th17 Cytokines Drive Inflammation in Takayasu Arteritis

Arthritis and Rheumatology, 2015
Cloé Comarmond, Anne Claire Desbois, Michelle Rosenzwajg   +2 more
exaly  

Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab

Annals of the Rheumatic Diseases, 2012
Frank Buttgereit, Andreas Radbruch, Falk Hiepe   +2 more
exaly  

A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Takayasu Arteritis

Arthritis and Rheumatology, 2017
David Cuthbertson, Nader Khalidi, Paul A Monach   +2 more
exaly